<?xml version="1.0" encoding="UTF-8"?>
<p>Although we were able to demonstrate the safety of the intervention and obtain an initial impression of the potential of our NPC cell line to affect parkinsonian motor symptoms, a limitation of the present study is the small heterogeneous patient sample size, a drawback we aim to address in future studies.</p>
